首页> 外文OA文献 >Uptake of Etoposide in CT-26 Cells of Colorectal Cancer Using Folate Targeted Dextran Stearate Polymeric Micelles
【2h】

Uptake of Etoposide in CT-26 Cells of Colorectal Cancer Using Folate Targeted Dextran Stearate Polymeric Micelles

机译:使用叶酸靶向葡聚糖硬脂酸盐聚合物胶束在结直肠癌CT-26细胞中吸收依托泊苷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Targeted drug delivery using folate receptors is one of the most interesting chemotherapeutic research areas over the past few years. A novel folate targeted copolymer was synthesized using dextran stearate coupled to folic acid. FT-IR and NMR spectroscopy were used to confirm successful conjugation. Micelles prepared using this copolymer were characterized for their particle size, zeta potential, critical micelle concentration (CMC), drug loading capacity, and release efficiency. Cytotoxicity and cellular uptake of the micelles were estimated using CT-26 colorectal carcinoma cell line. FT-IR and NMR spectroscopy confirmed production of folate grafted dextran stearate copolymer. Low CMC value indicates that the copolymers are suitable for preparation of stable micelles useful in parenteral dosage forms. Particle size and zeta potential of the targeted nanoparticles were 105.5±2.0 nm and −21.2 mV, respectively. IC50 of etoposide loaded in folate grafted dextran stearate enhanced about 20-fold compared to the pure drug (0.49±0.11 μg/mL versus 9.41±0.52 μg/mL). It seems that etoposide loaded in micelles of folate grafted dextran stearate copolymer is promising in reducing drug resistance of colorectal cancer by boosting etoposide cellular uptake.
机译:使用叶酸受体靶向给药是最有趣的化疗研究领域在过去几年中的一个。一种新的叶酸靶向共聚物使用耦合到叶酸葡聚糖硬脂酸合成。 FT-IR和NMR光谱法用于证实成功缀合。使用这种共聚物制备的胶束表征其粒径,zeta电位,临界胶束浓度(CMC),载药量,和释放效率。细胞毒性和胶束的细胞摄取用CT-26结肠癌细胞系进行估计。 FT-IR和NMR光谱证实生产叶酸接枝葡聚糖硬脂酸共聚物。低CMC值表示共聚物适用于制备在肠胃外剂型中有用的稳定胶束。所述靶向纳米颗粒的粒径和zeta电位分别为105.5±2.0 nm和-21.2 mV时,分别。依托泊苷的IC50叶酸接枝葡聚糖硬脂酸增强大约装载20倍相比,纯药(0.49±0.11微克/ mL对9.41±0.52微克/毫升)。这似乎在叶酸接枝葡聚糖硬脂酸共聚物的胶束装载的依托泊苷在由升压依托泊苷的细胞摄取减少结肠直肠癌的耐药性是有希望的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号